These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30246632)

  • 41. How can lipid nanocarriers improve transdermal delivery of olanzapine?
    Iqbal N; Vitorino C; Taylor KM
    Pharm Dev Technol; 2017 Jun; 22(4):587-596. PubMed ID: 27876425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined use of nanocarriers and physical methods for percutaneous penetration enhancement.
    Dragicevic N; Maibach H
    Adv Drug Deliv Rev; 2018 Mar; 127():58-84. PubMed ID: 29425769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
    Jain S; Patel N; Shah MK; Khatri P; Vora N
    J Pharm Sci; 2017 Feb; 106(2):423-445. PubMed ID: 27865609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
    Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
    Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delivery and targeting of nanoparticles into hair follicles.
    Fang CL; Aljuffali IA; Li YC; Fang JY
    Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of structural differences in hyperbranched polyglycerol–polyethylene glycol nanoparticles on dermal drug delivery and biocompatibility.
    Kumar S; Alnasif N; Fleige E; Kurniasih I; Kral V; Haase A; Luch A; Weindl G; Haag R; Schäfer-Korting M; Hedtrich S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):625-34. PubMed ID: 25445303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Int J Pharm; 2013 Feb; 443(1-2):26-38. PubMed ID: 23313344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liposomal formulation for dermal and transdermal drug delivery: past, present and future.
    Nounou MI; El-Khordagui LK; Khalafallah NA; Khalil SA
    Recent Pat Drug Deliv Formul; 2008; 2(1):9-18. PubMed ID: 19075893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers.
    Chen ZX; Li B; Liu T; Wang X; Zhu Y; Wang L; Wang XH; Niu X; Xiao Y; Sun Q
    Eur J Pharm Sci; 2017 Mar; 99():240-245. PubMed ID: 28039091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Engineering approaches to transdermal drug delivery: a tribute to contributions of prof. Robert Langer.
    Mitragotri S
    Skin Pharmacol Physiol; 2013; 26(4-6):263-76. PubMed ID: 23921113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Terpene composited lipid nanoparticles for enhanced dermal delivery of all-trans-retinoic acids.
    Charoenputtakun P; Pamornpathomkul B; Opanasopit P; Rojanarata T; Ngawhirunpat T
    Biol Pharm Bull; 2014; 37(7):1139-48. PubMed ID: 24805206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advanced Analgesic Drug Delivery and Nanobiotechnology.
    Stoicea N; Fiorda-Diaz J; Joseph N; Shabsigh M; Arias-Morales C; Gonzalez-Zacarias AA; Mavarez-Martinez A; Marjoribanks S; Bergese SD
    Drugs; 2017 Jul; 77(10):1069-1076. PubMed ID: 28470586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microwave as skin permeation enhancer for transdermal drug delivery of chitosan-5-fluorouracil nanoparticles.
    Nawaz A; Wong TW
    Carbohydr Polym; 2017 Feb; 157():906-919. PubMed ID: 27988008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prodrugs for transdermal drug delivery - trends and challenges.
    Ita KB
    J Drug Target; 2016 Sep; 24(8):671-8. PubMed ID: 26878159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting.
    Palmer BC; DeLouise LA
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27983701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promotion of the transdermal delivery of protein drugs by
    Tu Y; Wang X; Lu Y; Zhang H; Yu Y; Chen Y; Liu J; Sun Z; Cui L; Gao J; Zhong Y
    Int J Nanomedicine; 2016; 11():5549-5561. PubMed ID: 27822034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcending the Cutaneous Barrier Through Nanocarrier Exploration for Passive Delivery of Anti-hypertensive Drugs: A Critical Review.
    Kumar L; Utreja P
    Recent Pat Nanotechnol; 2020; 14(3):193-209. PubMed ID: 32427090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tailored dendritic core-multishell nanocarriers for efficient dermal drug delivery: A systematic top-down approach from synthesis to preclinical testing.
    Hönzke S; Gerecke C; Elpelt A; Zhang N; Unbehauen M; Kral V; Fleige E; Paulus F; Haag R; Schäfer-Korting M; Kleuser B; Hedtrich S
    J Control Release; 2016 Nov; 242():50-63. PubMed ID: 27349353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.